Abstract
Acute renal failure (ARF) occurs in 7% of patients admitted to the intensive care unit (ICU) (1). Previously, mortality exceeded 91%, but with the introduction of dialysis, this quickly fell to approximately 50% (2). Overall mortality for ARF has remained approximately 50%, associated with increasing comorbidity (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996; 24(2): 192–198.
Smith LH, Post RS, et al. Post traumatic renal insufficiency in military casualties. II. Management, use of an artificial kidney, prognosis. Am J Med 1955; 18:187.
Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66(4): 1613–1621.
Meyer TW, Walther JL, Pagtalunan ME, et al. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 2005; 68(2): 867–877.
Kramer P, Wigger W, Rieger J, et al. Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wschr 1977; 55: 1121–1122.
Ronco C, Bellomo R. Continuous renal replacement therapy: evolution in technology and current nomenclature. Kidney Int Suppl 1998; 66: S160–164.
Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346(5): 305–310.
Marshall MR, Golper TA, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 2001 (132): 252–257.
Naka T, Baldwin I, Bellomo R, Fealy N, Wan L. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 2004; 27(5): 380–387.
Zimmerman JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31(12): 2794–2801.
Nalesso F. Plasma filtration adsorption dialysis (PFAD): a new technology for blood purification. Int J Artif Organs 2005; 28(7): 731–738.
Silverstein ME, Ford C, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. New Eng J Med 1974; 291(15): 747–751.
Ronco C, Bellomo R, eds. Continuous high flux dialysis: an efficient renal replacement. Heidelberg: Springer Verlag; 1996.
Cole L, Bellomo R, Journois D, et al. High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27(6): 978–986.
Reeves JH, Butt WW, Shann F, et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999; 27(10): 2096–2104.
Ronco C, Brendolan A, d’Intini V, et al. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif 2003; 21(6): 409–416.
Marshall MR, Ma T, Galler D, et al. Sustained lowefficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19(4): 877–884.
Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36(2): 294–300.
Palevsky PM. Renal replacement therapy I: indications and timing. Crit Care Clin 2005; 21(2): 347–356.
Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288(20): 2547–2553.
Cantarovich F, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebocontrolled, multicenter trial. Am J Kidney Dis 2004; 44(3): 402–409.
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32(8): 1669–1677.
Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999; 258: 805–813.
van Bommel EF, Kalmeijer MD, Ponssen HH. Treatment of life-threatening lithium toxicity with highvolume continuous venovenous hemofiltration. Am J Nephrol 2000; 20(5): 408–411.
Maggiore Q, Pizzarelli F, Dattolo P, et al. Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrol Dial Transplant 2000; 15Suppl 1: 68–73.
Gotloib L, Barzilay E, Shustak A, et al. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986; 13(2): 123–132.
Tonnesen E, Hansen MB, Hohndorf K, et al. Cytokines in plasma and ultrafiltrate during continuous arteriovenous haemofiltration. Anaesth Intensive Care 1993; 21(6): 752–758.
Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30(1): 100–106.
Uchino S, Bellomo R, Goldsmith D, et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 2002; 28(5): 651–655.
Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002; 30(6): 1250–1255.
Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96(3-4): 132–143.
Costanzo MR, Saltzberg M, O’Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46(11): 2047–2051.
Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005; 46(11): 2043–2046.
Walters RJ, Fox NC, Crum WR, et al. Haemodialysis and cerebral oedema. Nephron 2001; 87(2): 143–147.
Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 1989; 12(7): 439–444.
Eknoyan G, Levin N. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis 2001; 37(1 Suppl 1): S5–6.
Drazen JM, Ingelfinger JR, Curfman GD. Removal of expression of concern: Schiffl H, et al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305–310. N Engl J Med 2003; 349(20): 1965.
Reeves JH, Butt WW. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter. ASAIO J 1995; 41(1): 100–104.
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemo filtration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356(9223): 26–30.
Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60(3): 1154–1163.
Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28(1): 29–37.
Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44(6): 1000–1007.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Reeves, J.H. (2008). Renal Replacement Therapy. In: Blakeley, S. (eds) Renal Failure and Replacement Therapies. Competency-Based Critical Care. Springer, London. https://doi.org/10.1007/978-1-84628-937-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-84628-937-8_10
Publisher Name: Springer, London
Print ISBN: 978-1-84628-936-1
Online ISBN: 978-1-84628-937-8
eBook Packages: MedicineMedicine (R0)